BackWeLeader Biomedical , Ltd. Overview

WeLeader Biomedical , Ltd. Total Liabilities

Track WeLeader Biomedical , Ltd.'s total liabilities ($1.3B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.32B
↑ 27.18% YoYΔ $282.09M vs prior year quarter

Peer trimmed avg / median

Loading

WeLeader Biomedical , Ltd. Total Liabilities History

Loading

WeLeader Biomedical , Ltd. vs. peers: Total Liabilities Comparison

Loading

WeLeader Biomedical , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

WeLeader Biomedical , Ltd. (7713.TWO) FAQ

As of the most recent data (June 2026), 7713.TWO shows a total liabilities of $1.3B. That compares with $1B in the prior-year period — up 27.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 7713.TWO's total liabilities is now $1.3B (was $1B) — a 27.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether WeLeader Biomedical , Ltd. is outperforming or lagging.

Tracking 7713.TWO's total liabilities over time shows whether WeLeader Biomedical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3B That compares with $1B in the prior-year period — up 27.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has WeLeader Biomedical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $1.3B) with ownership activity and broader fundamentals.